An experienced South African GP shares the frustration of reading of New Zealand’s GP shortages when she and her colleagues can face years of waiting before they can practice.
Regulating vaping – including allowing sales of nicotine-vaping liquids – is needed now to meet the Smokefree 2025 goal, says MP Nicky Wagner who has submitted a private member’s bill based on her work as former associate health minister.
Jacqui de Ruiter says if there's going to be a conversation about abortion, let it be open and honest.
New Zealand Initiative economist Eric Crampton responds to University of Otago researchers recent call for a UK-style soft drinks levy and their critique of the NZIER sugary drink tax report.
From 1 April 2018, the UK is putting in place a type of sugary drinks tax – actually a “soft drinks industry levy”. This blog reviews how they are doing it, early signs of its success, and ponders its relevance for NZ. We also take this opportunity to point out some problems with a recent NZIER Report on sugary drink taxes.
Criminologist Dr Julian Buchanan argues that New Zealand’s current policy on naxolone – the take-home antidote to drug overdoses – is showing a deadly indifference to a vulnerable group of people.
Surgeon Paul Anderson offers a free specialist review clinic, to a high needs community, that he believes could be a model for making a real difference to waiting list woes.
A young woman shares with HealthCentral the frustration she and her family feel as they struggle to navigate the mental health system to get the right help and support for her sister.
Historian Dr Warwick Brunton has studied all our major mental health inquiries of the past 150 years. He thinks this latest inquiry has the potential to offer ‘generational hope’ if it has the courage – and resourcing – to learn from the mistakes of the past and do things differently.
Criminologist Dr Julian Buchanan says drug reform is overdue but argues that legal regulation of prohibited drugs, like cannabis, may only benefit those who can afford legally-approved drugs.